Table 2.
Antidepressant use by class among pregnant women, NAMCS/NHAMCS 2006–2010.
| Name | Weighted % |
|---|---|
| Selective serotonin reuptake inhibitors (SSRI) | 68.3% |
| Selective serotonin-norepinephrine reuptake inhibitors (SSNRI) | 10.6% |
| Phenylpiperazine | 2.7% |
| Tricyclic | 2.1% |
| Tetracyclic | 0.7% |
| Miscellaneous | 17.4% |
Note: percentages do not add up to 100% because some patients are taking multiple drugs simultaneously.